Shalini Sundar, MD
Nephrology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: 052571 · 052685 · 052722 · 752505 · Washington Hospital. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Sundar’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A93518 · Current
Licensed to practise in California · since 2005 · expires 2027-11-30 · Bangalore University, Bangalore Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$272,082
Medicare paid this office $272,082 for 368 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 169 | $54,879 | $75 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $47,152 | $286 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $42,246 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 138 | $31,981 | $166 |
| Return visit (30+ min) | 104 | $27,996 | $115 |
See all 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 169 | $54,879 | $75 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 32 | $47,152 | $286 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $42,246 | $114 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 138 | $31,981 | $166 |
| Return visit (30+ min) | 104 | $27,996 | $115 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $18,807 | $342 |
| Short return visit (20+ min) | 101 | $14,956 | $74 |
| Dialysis services, 1 physician visit per month (20 years or older) | 25 | $10,967 | $196 |
| Hemodialysis procedure with physician evaluation | 39 | $9,249 | $68 |
| New patient visit (45+ min) | 30 | $4,555 | $152 |
| Long return visit (40+ min) | 20 | $2,932 | $140 |
Who their Medicare patients are
368 Original Medicare patients in 2024. Average age 77 · Under 65 9% · 85 and older 26% · Women 52% · Also on Medicaid 59% · Health risk score 3.70. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 67% · Coronary heart disease 51% · Heart failure 50% · Atrial fibrillation 36% · COPD 25% · Dementia 24% · Depression 19% · Stroke 16% · Cancer 15%.
The office billed $586,597, Medicare allowed $345,740 and paid $272,082; for 2,307 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 368 | 2,307 | 77 | 3.70 | $586,597 | $272,082 |
| 2023 | 399 | 2,728 | 78 | 3.64 | $683,394 | $297,701 |
| 2022 | 397 | 2,505 | 76 | 3.70 | $696,118 | $289,365 |
| 2021 | 416 | 2,759 | 75 | 3.79 | $762,609 | $315,762 |
| 2020 | 381 | 3,182 | 75 | 4.18 | $835,827 | $320,636 |
| 2019 | 370 | 2,585 | 76 | 4.26 | $740,187 | $289,234 |
| 2018 | 369 | 2,483 | 75 | 4.25 | $726,009 | $282,853 |
| 2017 | 383 | 2,663 | 74 | 4.03 | $714,973 | $273,141 |
| 2016 | 318 | 2,165 | 75 | 4.32 | $593,408 | $220,385 |
| 2015 | 317 | 2,345 | 75 | 4.16 | $664,056 | $249,954 |
| 2014 | 320 | 2,395 | 74 | 4.38 | $605,208 | $240,944 |
| 2013 | 339 | 2,753 | 73 | 4.49 | $586,072 | $252,695 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 208 | $75,943 | $72 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 31 | $51,072 | $270 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 138 | $42,205 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 192 | $38,834 | $157 |
| Return visit (30+ min) | 98 | $23,416 | $108 |
| Dialysis services, 1 physician visit per month (20 years or older) | 28 | $16,236 | $189 |
| Short return visit (20+ min) | 102 | $13,373 | $68 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $12,355 | $325 |
| Hemodialysis procedure with physician evaluation | 48 | $9,815 | $65 |
| New patient visit (45+ min) | 24 | $3,072 | $128 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $1,601 | $44 |
2022: 10 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $67,747 | $273 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 196 | $55,381 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 148 | $40,769 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 182 | $40,049 | $177 |
| Return visit (30+ min) | 97 | $25,052 | $109 |
| Dialysis services, 1 physician visit per month (20 years or older) | 33 | $21,147 | $187 |
| Short return visit (20+ min) | 95 | $10,824 | $67 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 13 | $10,213 | $329 |
| Hemodialysis procedure with physician evaluation | 44 | $5,440 | $66 |
| New patient visit (45+ min) | 29 | $4,298 | $148 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 222 | $63,501 | $65 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 44 | $59,238 | $274 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 175 | $44,428 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $43,870 | $94 |
| Dialysis services, 1 physician visit per month (20 years or older) | 40 | $29,527 | $187 |
| Return visit (30+ min) | 94 | $24,610 | $103 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $22,330 | $333 |
| Short return visit (20+ min) | 88 | $9,270 | $59 |
| Hemodialysis procedure with physician evaluation | 40 | $6,510 | $66 |
| New patient visit (45+ min) | 30 | $4,380 | $146 |
| Long return visit (40+ min) | 11 | $1,752 | $135 |
2020: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 226 | $87,530 | $66 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 48 | $55,713 | $225 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 189 | $44,988 | $184 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $36,830 | $95 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 38 | $27,012 | $262 |
| Dialysis services, 1 physician visit per month (20 years or older) | 44 | $22,265 | $175 |
| Return visit (30+ min) | 68 | $12,387 | $81 |
| Hemodialysis procedure with physician evaluation | 46 | $8,620 | $67 |
| Short return visit (20+ min) | 75 | $5,487 | $45 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $2,528 | $68 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 27 | $2,009 | $36 |
| New patient visit (45+ min) | 13 | $1,681 | $129 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,012 | $48 |
2019: 12 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $59,204 | $261 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 193 | $54,628 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $38,702 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 157 | $37,380 | $182 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 41 | $36,945 | $220 |
| Return visit (30+ min) | 80 | $20,201 | $94 |
| Short return visit (20+ min) | 89 | $11,583 | $67 |
| Hemodialysis procedure with physician evaluation | 41 | $7,255 | $66 |
| Dialysis services, 1 physician visit per month (20 years or older) | 18 | $6,537 | $172 |
| New patient visit (45+ min) | 28 | $3,899 | $139 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $1,659 | $35 |
| Hemodialysis procedure requiring repeated evaluation | 13 | $1,507 | $94 |
2018: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 184 | $60,443 | $92 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 39 | $58,757 | $254 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 177 | $46,440 | $65 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 161 | $37,119 | $179 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 42 | $29,974 | $216 |
| Return visit (30+ min) | 75 | $18,156 | $95 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $8,256 | $168 |
| Short return visit (20+ min) | 51 | $5,906 | $62 |
| Hemodialysis procedure with physician evaluation | 45 | $5,401 | $64 |
| New patient visit (45+ min) | 25 | $3,431 | $137 |
| Hemodialysis procedure requiring repeated evaluation | 24 | $3,312 | $92 |
2017: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 214 | $65,464 | $63 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 174 | $44,372 | $91 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 43 | $44,226 | $212 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 169 | $38,068 | $177 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 32 | $34,250 | $250 |
| Return visit (30+ min) | 67 | $14,045 | $93 |
| Dialysis services, 1 physician visit per month (20 years or older) | 21 | $8,245 | $165 |
| Short return visit (20+ min) | 68 | $8,111 | $56 |
| Hemodialysis procedure with physician evaluation | 45 | $6,482 | $63 |
| Hemodialysis procedure requiring repeated evaluation | 22 | $3,084 | $91 |
| New patient visit (45+ min) | 19 | $2,637 | $139 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 14 | $648 | $34 |
2016: 11 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $53,389 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 174 | $49,662 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 132 | $35,367 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 130 | $29,837 | $173 |
| Return visit (30+ min) | 55 | $12,599 | $93 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 16 | $11,028 | $245 |
| Dialysis services, 1 physician visit per month (20 years or older) | 22 | $8,019 | $164 |
| Short return visit (20+ min) | 67 | $7,669 | $59 |
| Hemodialysis procedure with physician evaluation | 38 | $5,370 | $62 |
| Hemodialysis procedure requiring repeated evaluation | 16 | $3,311 | $89 |
| New patient visit (45+ min) | 16 | $2,135 | $133 |
2015: 11 services
| Dialysis services, 2-3 physician visits per month (20 years or older) | 40 | $60,936 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 176 | $51,219 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 165 | $44,358 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 146 | $34,717 | $174 |
| Return visit (30+ min) | 57 | $15,098 | $96 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 20 | $13,597 | $247 |
| Dialysis services, 1 physician visit per month (20 years or older) | 20 | $7,052 | $164 |
| Short return visit (20+ min) | 50 | $6,756 | $60 |
| Hemodialysis procedure with physician evaluation | 37 | $5,732 | $62 |
| Hemodialysis procedure requiring repeated evaluation | 27 | $4,034 | $90 |
| New patient visit (45+ min) | 20 | $2,568 | $128 |
2014: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 195 | $62,076 | $62 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $45,474 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 156 | $42,323 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 141 | $34,923 | $174 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 26 | $22,287 | $248 |
| Return visit (30+ min) | 46 | $9,475 | $89 |
| Hemodialysis procedure with physician evaluation | 36 | $5,372 | $62 |
| Dialysis services, 1 physician visit per month (20 years or older) | 14 | $4,874 | $162 |
| Short return visit (20+ min) | 43 | $4,480 | $61 |
| New patient visit (45+ min) | 22 | $2,973 | $135 |
| Hemodialysis procedure requiring repeated evaluation | 18 | $2,961 | $90 |
2013: 13 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 234 | $80,440 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 187 | $44,333 | $170 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 35 | $42,927 | $207 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 109 | $33,249 | $87 |
| Dialysis services, 1 physician visit per month (20 years or older) | 24 | $8,972 | $163 |
| Return visit (30+ min) | 45 | $7,504 | $90 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 15 | $7,298 | $243 |
| Hemodialysis procedure with physician evaluation | 62 | $7,278 | $61 |
| Hemodialysis procedure requiring repeated evaluation | 40 | $7,059 | $87 |
| Short return visit (20+ min) | 38 | $4,896 | $59 |
| New patient visit (45+ min) | 20 | $2,778 | $139 |
| Initial hospital observation care per day, typically 70 minutes | 12 | $2,179 | $156 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 32 | $1,736 | $33 |
Medicaid work
$78,602 in 2024
Medicaid paid $78,602 for 1,416 billed services this clinician did in 2024, up to 28 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 698 | $26,252 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 134 | $15,077 |
| 1ST HOSP IP/OBS HIGH 75 | 167 | $12,065 |
| Return visit (30+ min) | 145 | $10,707 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 207 | $10,188 |
| Short return visit (20+ min) | 52 | $2,532 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 13 | $1,780 |
| 2024 | 1,416 | 7 | 28 | $78,602 |
| 2023 | 1,526 | 6 | 27 | $76,169 |
| 2022 | 550 | 5 | 17 | $37,333 |
| 2021 | 215 | 4 | 22 | $9,136 |
| 2020 | 93 | 2 | 16 | $3,217 |
| 2019 | 117 | 3 | 14 | $7,115 |
| 2018 | 99 | 3 | 14 | $8,561 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 867 | $28,499 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 118 | $15,314 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 255 | $13,575 |
| 1ST HOSP IP/OBS HIGH 75 | 178 | $12,187 |
| Return visit (30+ min) | 81 | $5,183 |
| Short return visit (20+ min) | 27 | $1,411 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 96 | $12,767 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 124 | $9,345 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 271 | $9,316 |
| 1ST HOSP IP/OBS HIGH 75 | 42 | $4,245 |
| Return visit (30+ min) | 17 | $1,660 |
2021
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 155 | $4,413 |
| 1ST HOSP IP/OBS HIGH 75 | 29 | $2,784 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 14 | $1,871 |
| Return visit (30+ min) | 17 | $68 |
2020
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 78 | $1,815 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $1,403 |
2019
| Return visit (30+ min) | 39 | $2,847 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 46 | $2,701 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 32 | $1,567 |
2018
| Return visit (30+ min) | 54 | $3,777 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 12 | $2,608 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $2,176 |
Drugs they prescribed that Part D paid
$353,343
Pharmacies billed $353,343 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,324) in 2024. At or below the middle of the specialty; the typical nephrology clinician is at 0%.
1,029 generic and 295 brand-name prescriptions · $353,343 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 73 | $83,006 | $1,137 |
| Lokelma | 37 | $65,320 | $1,765 |
| Rayaldee | 38 | $47,057 | $1,238 |
| Kerendia | 20 | $27,680 | $1,384 |
| Jardiance | 15 | $19,705 | $1,314 |
See all 25 drugs
| Farxiga | 73 | $83,006 | $1,137 |
| Lokelma | 37 | $65,320 | $1,765 |
| Rayaldee | 38 | $47,057 | $1,238 |
| Kerendia | 20 | $27,680 | $1,384 |
| Jardiance | 15 | $19,705 | $1,314 |
| Procrit | 26 | $13,857 | $533 |
| Sevelamer Carbonate | 34 | $8,786 | $258 |
| Cinacalcet | 29 | $5,557 | $192 |
| Retacrit | 26 | $5,484 | $211 |
| Calcitriol | 157 | $3,390 | $22 |
| Calcium Acetate | 18 | $3,270 | $182 |
| Bumetanide | 47 | $2,104 | $45 |
| Potassium Chloride | 71 | $2,030 | $29 |
| Terazosin | 61 | $1,290 | $21 |
| Hydralazine | 60 | $1,062 | $18 |
| Furosemide | 143 | $1,016 | $7 |
| Midodrine | 15 | $868 | $58 |
| Amlodipine Besylate | 104 | $779 | $7 |
| Losartan | 64 | $750 | $12 |
| Valsartan | 13 | $671 | $52 |
| Lisinopril | 19 | $313 | $16 |
| Carvedilol | 20 | $276 | $14 |
| Hydrochlorothiazide | 41 | $228 | $6 |
| Metoprolol | 34 | $185 | $5 |
| Prednisone | 14 | $147 | $11 |
Year by year
| 2024 | 1,324 | 189 | 0% (0) | 22% | $353,343 |
| 2023 | 1,270 | 178 | 0% (0) | 22% | $463,570 |
| 2022 | 1,177 | 164 | 0% (0) | 23% | $439,899 |
| 2021 | 1,229 | 145 | 0% (0) | 21% | $285,811 |
| 2020 | 1,234 | 135 | 0% (0) | 23% | $301,951 |
| 2019 | 1,151 | 126 | None | 21% | $213,130 |
| 2018 | 1,223 | 104 | 0% (0) | 22% | $296,976 |
| 2017 | 1,368 | 104 | 0% (0) | 36% | $371,779 |
| 2016 | 1,104 | 94 | None | 36% | $290,857 |
| 2015 | 1,112 | 79 | None | 37% | $269,089 |
| 2014 | 1,094 | 80 | 1% (13) | 41% | $209,884 |
| 2013 | 845 | 80 | None | None | $111,287 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 26 drugs
| Lokelma | 50 | $88,842 | $1,777 |
| Rayaldee | 54 | $81,231 | $1,504 |
| Farxiga | 52 | $71,526 | $1,375 |
| Renvela | 12 | $53,206 | $4,434 |
| Velphoro | 22 | $50,133 | $2,279 |
| Sevelamer Carbonate | 40 | $25,773 | $644 |
| Procrit | 20 | $14,374 | $719 |
| Kerendia | 14 | $13,500 | $964 |
| Cinacalcet | 27 | $9,915 | $367 |
| Calcitriol | 136 | $4,735 | $35 |
| Potassium Chloride | 46 | $3,299 | $72 |
| Bumetanide | 57 | $3,226 | $57 |
| Calcium Acetate | 27 | $3,031 | $112 |
| Midodrine | 29 | $2,364 | $82 |
| Losartan | 73 | $2,164 | $30 |
| Amlodipine Besylate | 95 | $1,893 | $20 |
| Terazosin | 63 | $1,737 | $28 |
| Furosemide | 140 | $1,694 | $12 |
| Hydralazine | 44 | $1,355 | $31 |
| Nifedipine Er | 11 | $1,143 | $104 |
| Tamsulosin | 13 | $574 | $44 |
| Metoprolol | 32 | $508 | $16 |
| Carvedilol | 19 | $489 | $26 |
| Lidocaine-Prilocaine | 17 | $267 | $16 |
| Lisinopril | 16 | $170 | $11 |
| Hydrochlorothiazide | 28 | $149 | $5 |
2022: 25 drugs
| Lokelma | 63 | $85,909 | $1,364 |
| Velphoro | 30 | $79,855 | $2,662 |
| Renvela | 21 | $76,339 | $3,635 |
| Rayaldee | 44 | $62,755 | $1,426 |
| Sevelamer Carbonate | 74 | $58,657 | $793 |
| Farxiga | 17 | $22,947 | $1,350 |
| Procrit | 12 | $13,118 | $1,093 |
| Cinacalcet | 18 | $5,536 | $308 |
| Calcium Acetate | 53 | $5,414 | $102 |
| Midodrine | 39 | $3,451 | $88 |
| Calcitriol | 90 | $3,000 | $33 |
| Bumetanide | 41 | $2,215 | $54 |
| Potassium Chloride | 47 | $1,627 | $35 |
| Furosemide | 131 | $1,514 | $12 |
| Amlodipine Besylate | 94 | $1,437 | $15 |
| Terazosin | 59 | $1,434 | $24 |
| Losartan | 68 | $1,064 | $16 |
| Hydralazine | 27 | $783 | $29 |
| Metolazone | 12 | $748 | $62 |
| Metoprolol | 45 | $739 | $16 |
| Carvedilol | 14 | $404 | $29 |
| Prednisone | 15 | $268 | $18 |
| Clonidine | 15 | $246 | $16 |
| Lisinopril | 15 | $220 | $15 |
| Hydrochlorothiazide | 16 | $86 | $5 |
2021: 26 drugs
| Velphoro | 26 | $69,251 | $2,664 |
| Lokelma | 56 | $66,635 | $1,190 |
| Renvela | 28 | $49,767 | $1,777 |
| Procrit | 31 | $36,427 | $1,175 |
| Sevelamer Carbonate | 90 | $18,685 | $208 |
| Rayaldee | 11 | $12,993 | $1,181 |
| Cinacalcet | 15 | $5,176 | $345 |
| Calcium Acetate | 44 | $3,376 | $77 |
| Midodrine | 60 | $2,669 | $44 |
| Calcitriol | 70 | $2,547 | $36 |
| Terazosin | 74 | $1,558 | $21 |
| Amlodipine Besylate | 97 | $1,305 | $13 |
| Potassium Chloride | 48 | $1,231 | $26 |
| Bumetanide | 21 | $1,079 | $51 |
| Furosemide | 150 | $1,069 | $7 |
| Hydralazine | 52 | $983 | $19 |
| Losartan | 58 | $767 | $13 |
| Metoprolol | 63 | $634 | $10 |
| Lidocaine-Prilocaine | 15 | $298 | $20 |
| Carvedilol | 11 | $248 | $23 |
| Clonidine | 23 | $201 | $9 |
| Lisinopril | 13 | $192 | $15 |
| Doxazosin Mesylate | 15 | $191 | $13 |
| Prednisone | 16 | $178 | $11 |
| Torsemide | 12 | $154 | $13 |
| Hydrochlorothiazide | 15 | $70 | $5 |
2020: 28 drugs
| Velphoro | 41 | $85,395 | $2,083 |
| Renvela | 35 | $80,928 | $2,312 |
| Procrit | 34 | $27,771 | $817 |
| Lokelma | 21 | $26,334 | $1,254 |
| Sevelamer Carbonate | 97 | $18,639 | $192 |
| Cinacalcet | 34 | $17,184 | $505 |
| Clinolipid | 12 | $4,179 | $348 |
| Calcium Acetate | 41 | $3,677 | $90 |
| Calcitriol | 75 | $2,786 | $37 |
| Midodrine | 63 | $2,559 | $41 |
| Hydralazine | 71 | $1,244 | $18 |
| Bumetanide | 12 | $1,181 | $98 |
| Amlodipine Besylate | 135 | $1,118 | $8 |
| Metolazone | 18 | $939 | $52 |
| Terazosin | 50 | $892 | $18 |
| Potassium Chloride | 34 | $742 | $22 |
| Furosemide | 110 | $694 | $6 |
| Metoprolol | 52 | $522 | $10 |
| Losartan | 37 | $477 | $13 |
| Lidocaine-Prilocaine | 23 | $380 | $17 |
| Doxazosin Mesylate | 16 | $293 | $18 |
| Lisinopril | 22 | $280 | $13 |
| Tamsulosin | 12 | $207 | $17 |
| Prednisone | 20 | $164 | $8 |
| Pantoprazole | 12 | $144 | $12 |
| Carvedilol | 19 | $116 | $6 |
| Clonidine | 16 | $89 | $6 |
| Hydrochlorothiazide | 11 | $52 | $5 |
2019: 21 drugs
| Renvela | 34 | $89,661 | $2,637 |
| Velphoro | 23 | $29,451 | $1,280 |
| Sevelamer Carbonate | 84 | $22,313 | $266 |
| Procrit | 33 | $17,007 | $515 |
| Calcitriol | 130 | $3,707 | $29 |
| Calcium Acetate | 31 | $2,881 | $93 |
| Midodrine | 29 | $1,236 | $43 |
| Potassium Chloride | 39 | $1,206 | $31 |
| Hydralazine | 58 | $1,058 | $18 |
| Amlodipine Besylate | 111 | $931 | $8 |
| Metolazone | 12 | $882 | $74 |
| Furosemide | 141 | $805 | $6 |
| Losartan | 37 | $531 | $14 |
| Metoprolol | 47 | $519 | $11 |
| Terazosin | 32 | $456 | $14 |
| Clonidine | 20 | $245 | $12 |
| Lisinopril | 21 | $226 | $11 |
| Chlorthalidone | 12 | $221 | $18 |
| Tamsulosin | 19 | $211 | $11 |
| Carvedilol | 33 | $205 | $6 |
| Hydrochlorothiazide | 15 | $141 | $9 |
2018: 26 drugs
| Renvela | 106 | $176,067 | $1,661 |
| Sevelamer Carbonate | 69 | $53,941 | $782 |
| Velphoro | 19 | $26,947 | $1,418 |
| Procrit | 16 | $9,852 | $616 |
| Lanthanum Carbonate | 11 | $8,691 | $790 |
| Calcitriol | 157 | $3,199 | $20 |
| Calcium Acetate | 44 | $1,733 | $39 |
| Midodrine | 44 | $1,193 | $27 |
| Sps | 13 | $755 | $58 |
| Labetalol | 14 | $722 | $52 |
| Amlodipine Besylate | 95 | $605 | $6 |
| Hydralazine | 56 | $581 | $10 |
| Furosemide | 143 | $557 | $4 |
| Chlorthalidone | 28 | $532 | $19 |
| Metoprolol | 65 | $518 | $8 |
| Metolazone | 11 | $368 | $33 |
| Metoprolol | 19 | $349 | $18 |
| Terazosin | 21 | $298 | $14 |
| Clonidine | 30 | $262 | $9 |
| Losartan | 31 | $239 | $8 |
| Hydrochlorothiazide | 27 | $137 | $5 |
| Prednisone | 13 | $129 | $10 |
| Lisinopril | 22 | $105 | $5 |
| Enalapril Maleate | 11 | $100 | $9 |
| Carvedilol | 18 | $90 | $5 |
| Famotidine | 14 | $80 | $6 |
2017: 27 drugs
| Renvela | 132 | $208,057 | $1,576 |
| Sensipar | 51 | $67,302 | $1,320 |
| Prosol | 48 | $18,436 | $384 |
| Procrit | 20 | $11,300 | $565 |
| Intralipid | 45 | $8,871 | $197 |
| Calcitriol | 119 | $2,792 | $23 |
| Dextrose in Water | 48 | $2,172 | $45 |
| Kionex | 19 | $1,625 | $86 |
| Esomeprazole Magnesium | 11 | $1,543 | $140 |
| Midodrine | 39 | $1,449 | $37 |
| Calcium Acetate | 34 | $1,374 | $40 |
| Hydralazine | 58 | $502 | $9 |
| Metoprolol | 105 | $478 | $5 |
| Nifedipine Er | 12 | $469 | $39 |
| Furosemide | 128 | $378 | $3 |
| Terazosin | 49 | $344 | $7 |
| Amlodipine Besylate | 80 | $256 | $3 |
| Klor-Con Sprinkle | 16 | $239 | $15 |
| Metoprolol | 15 | $234 | $16 |
| Losartan | 34 | $167 | $5 |
| Clonidine | 28 | $160 | $6 |
| Prednisone | 24 | $144 | $6 |
| Enalapril Maleate | 11 | $130 | $12 |
| Hydrochlorothiazide | 21 | $108 | $5 |
| Lisinopril | 25 | $88 | $4 |
| Carvedilol | 19 | $80 | $4 |
| Famotidine | 12 | $23 | $2 |
2016: 22 drugs
| Renvela | 122 | $161,184 | $1,321 |
| Sensipar | 69 | $62,360 | $904 |
| Fosrenol | 23 | $27,306 | $1,187 |
| Calcium Acetate | 56 | $3,927 | $70 |
| Calcitriol | 95 | $2,358 | $25 |
| Sps | 15 | $2,164 | $144 |
| Paricalcitol | 11 | $2,005 | $182 |
| Midodrine | 34 | $1,504 | $44 |
| Lidocaine-Prilocaine | 20 | $861 | $43 |
| Metoprolol | 74 | $551 | $7 |
| Furosemide | 117 | $506 | $4 |
| Hydralazine | 51 | $465 | $9 |
| Nifedipine Er | 15 | $406 | $27 |
| Terazosin | 44 | $354 | $8 |
| Amlodipine Besylate | 56 | $288 | $5 |
| Losartan | 56 | $237 | $4 |
| Pantoprazole | 12 | $203 | $17 |
| Lisinopril | 30 | $164 | $5 |
| Enalapril Maleate | 12 | $147 | $12 |
| Famotidine | 13 | $119 | $9 |
| Prednisone | 23 | $99 | $4 |
| Clonidine | 13 | $45 | $3 |
2015: 28 drugs
| Renvela | 132 | $175,182 | $1,327 |
| Sensipar | 63 | $49,177 | $781 |
| Fosrenol | 12 | $10,274 | $856 |
| Calcium Acetate | 49 | $3,375 | $69 |
| Paricalcitol | 11 | $2,339 | $213 |
| Benicar | 11 | $2,161 | $196 |
| Kionex | 15 | $2,045 | $136 |
| Midodrine | 35 | $1,614 | $46 |
| Calcitriol | 63 | $1,384 | $22 |
| Lidocaine-Prilocaine | 18 | $988 | $55 |
| Potassium Chloride | 37 | $781 | $21 |
| Hydralazine | 50 | $694 | $14 |
| Nifedipine Er | 16 | $672 | $42 |
| Amlodipine Besylate | 72 | $584 | $8 |
| Metoprolol | 62 | $498 | $8 |
| Metolazone | 11 | $430 | $39 |
| Furosemide | 113 | $403 | $4 |
| Tamsulosin | 18 | $291 | $16 |
| Losartan | 68 | $284 | $4 |
| Terazosin | 30 | $283 | $9 |
| Lisinopril | 22 | $242 | $11 |
| Pantoprazole | 12 | $221 | $18 |
| Levothyroxine | 14 | $172 | $12 |
| Prednisone | 17 | $171 | $10 |
| Paroxetine | 17 | $144 | $8 |
| Enalapril Maleate | 12 | $142 | $12 |
| Clonidine | 18 | $108 | $6 |
| Simvastatin | 12 | $25 | $2 |
2014: 26 drugs
| Renvela | 103 | $107,830 | $1,047 |
| Sensipar | 51 | $28,375 | $556 |
| Fosrenol | 30 | $23,944 | $798 |
| Prosol | 28 | $9,910 | $354 |
| Calcium Acetate | 56 | $6,271 | $112 |
| Nexium | 13 | $3,159 | $243 |
| Kionex | 32 | $2,921 | $91 |
| Intralipid | 18 | $2,358 | $131 |
| Midodrine | 34 | $1,969 | $58 |
| Calcitriol | 62 | $1,627 | $26 |
| Dextrose in Water | 28 | $1,190 | $43 |
| Hydralazine | 58 | $1,117 | $19 |
| Potassium Chloride | 25 | $678 | $27 |
| Amlodipine Besylate | 75 | $537 | $7 |
| Terazosin | 62 | $515 | $8 |
| Nifedipine Er | 14 | $412 | $29 |
| Metoprolol | 43 | $319 | $7 |
| Furosemide | 76 | $283 | $4 |
| Pantoprazole | 13 | $246 | $19 |
| Lisinopril | 33 | $187 | $6 |
| Tamsulosin | 16 | $175 | $11 |
| Losartan | 26 | $172 | $7 |
| Clonidine | 20 | $119 | $6 |
| Hydrocodone-Acetaminophen | 12 | $92 | $8 |
| Enalapril Maleate | 11 | $58 | $5 |
| Simvastatin | 12 | $57 | $5 |
2013: 21 drugs
| Renvela | 79 | $55,030 | $697 |
| Sensipar | 26 | $16,274 | $626 |
| Fosrenol | 12 | $8,902 | $742 |
| Calcium Acetate | 54 | $5,983 | $111 |
| Calcitriol | 74 | $2,883 | $39 |
| Nexium | 12 | $2,608 | $217 |
| Midodrine | 20 | $1,356 | $68 |
| Kionex | 11 | $1,237 | $112 |
| Hydralazine | 33 | $1,076 | $33 |
| Amlodipine Besylate | 96 | $870 | $9 |
| Terazosin | 69 | $549 | $8 |
| Furosemide | 65 | $310 | $5 |
| Metoprolol | 44 | $303 | $7 |
| Metoprolol | 13 | $276 | $21 |
| Pantoprazole | 13 | $229 | $18 |
| Tamsulosin | 14 | $188 | $13 |
| Losartan | 12 | $154 | $13 |
| Clonidine | 19 | $142 | $7 |
| Lisinopril | 22 | $128 | $6 |
| Simvastatin | 12 | $85 | $7 |
| Enalapril Maleate | 12 | $45 | $4 |
Money from drug and device companies
$808 in 2025
| 2025 | 10 | 37 | None | $808 |
| 2024 | 13 | 57 | None | $1,197 |
| 2023 | 12 | 46 | None | $903 |
| 2022 | 12 | 66 | None | $1,247 |
| 2021 | 8 | 46 | None | $811 |
| 2020 | 6 | 27 | None | $528 |
| 2019 | 9 | 32 | None | $607 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Fresenius USA Marketing | Velphoro | $256 | 15 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $180 | 7 payments
|
| Novartis Pharmaceuticals | Fabhalta | $88 | 3 payments
|
| Amgen | Krystexxa | $70 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $59 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $50 | 2 payments
|
See all 37 published payments
| Vifor Pharma | Meals · 2025-12-03 | Veltassa | $23 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-26 | Kerendia | $24 |
| Mallinckrodt Hospital Products | Meals · 2025-11-20 | Acthar | $28 |
| Amgen | Meals · 2025-11-06 | Tavneos | $24 |
| Fresenius USA Marketing | Meals · 2025-09-16 | Velphoro | $23 |
| Fresenius USA Marketing | Meals · 2025-09-04 | Velphoro | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-08-27 | Kerendia | $28 |
| Fresenius USA Marketing | Meals · 2025-08-13 | Velphoro | $24 |
| Mallinckrodt Hospital Products | Meals · 2025-07-30 | Acthar | $31 |
| Fresenius USA Marketing | Meals · 2025-07-29 | Velphoro | $21 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-03 | Kerendia | $27 |
| Fresenius USA Marketing | Meals · 2025-06-25 | Velphoro | $25 |
| Fresenius USA Marketing | Meals · 2025-06-18 | Velphoro | $17 |
| Fresenius USA Marketing | Meals · 2025-06-18 | Velphoro | $7 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-06-05 | Kerendia | $31 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-21 | Kerendia | $28 |
| Fresenius USA Marketing | Meals · 2025-05-21 | Velphoro | $24 |
| Apellis Pharmaceuticals | Meals · 2025-05-14 | None | $15 |
| Calliditas Therapeutics US | Meals · 2025-05-08 | Tarpeyo | $25 |
| Amgen | Meals · 2025-05-07 | Krystexxa | $29 |
| Novartis Pharmaceuticals | Meals · 2025-04-30 | Fabhalta | $32 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-17 | Kerendia | $20 |
| Fresenius USA Marketing | Meals · 2025-04-08 | Velphoro | $2 |
| Fresenius USA Marketing | Meals · 2025-04-08 | Velphoro | $19 |
| OPKO Pharmaceuticals | Education · 2025-03-05 | Rayaldee | $18 |
| Fresenius USA Marketing | Meals · 2025-03-05 | Velphoro | $19 |
| Fresenius USA Marketing | Meals · 2025-03-05 | Velphoro | $6 |
| Fresenius USA Marketing | Meals · 2025-02-27 | Velphoro | $8 |
| Fresenius USA Marketing | Meals · 2025-02-27 | Velphoro | $16 |
| Amgen | Meals · 2025-02-18 | Krystexxa | $17 |
| Novartis Pharmaceuticals | Meals · 2025-02-11 | Fabhalta | $30 |
| Calliditas Therapeutics US | Meals · 2025-01-29 | Tarpeyo | $25 |
| Ardelyx | Meals · 2025-01-28 | Ibsrela | $32 |
| OPKO Pharmaceuticals | Education · 2025-01-22 | Rayaldee | $17 |
| Fresenius USA Marketing | Meals · 2025-01-22 | Velphoro | $24 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-10 | Kerendia | $24 |
| Novartis Pharmaceuticals | Meals · 2025-01-07 | Fabhalta | $27 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,197
| Amgen | Krystexxa | $222 | 14 payments
|
| Fresenius USA Marketing | Velphoro | $209 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $141 | 7 payments
|
| OPKO Pharmaceuticals | Rayaldee | $107 | 5 payments
|
| Calliditas Therapeutics US | Tarpeyo | $98 | 4 payments
|
| Ardelyx | Ibsrela | $82 | 4 payments
|
| Lilly USA | Jardiance | $81 | 3 payments
|
| Novartis Pharmaceuticals | Fabhalta | $73 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $59 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $58 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $25 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $22 | 1 payment
|
| Xeris Pharmaceuticals | Keveyis | $17 | 1 payment
|
2023: $903
| AstraZeneca Pharmaceuticals LP | Farxiga | $322 | 16 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $136 | 5 payments
|
| Amgen | Epogen | $93 | 3 payments
|
| Vifor Pharma | Veltassa | $76 | 4 payments
|
| OPKO Pharmaceuticals | Rayaldee | $73 | 5 payments
|
| GlaxoSmithKline | Benlysta | $65 | 3 payments
|
| Calliditas Therapeutics US | Tarpeyo | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $26 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $23 | 1 payment
|
| Novartis Pharmaceuticals | None | $22 | 1 payment
|
| Ardelyx | Ibsrela | $21 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $20 | 1 payment
|
2022: $1,247
| OPKO Pharmaceuticals | Rayaldee | $229 | 15 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $189 | 11 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $172 | 6 payments
|
| Fresenius USA Marketing | Velphoro | $167 | 9 payments
|
| Horizon Therapeutics plc | Krystexxa | $136 | 8 payments
|
| Vifor Pharma | Veltassa | $124 | 6 payments
|
| Amgen | Parsabiv | $51 | 2 payments
|
| Akebia Therapeutics | Auryxia | $50 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $46 | 2 payments
|
| GlaxoSmithKline | Benlysta | $44 | 2 payments
|
| Daiichi Sankyo | Injectafer | $20 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $18 | 1 payment
|
2021: $811
| OPKO Pharmaceuticals | Rayaldee | $231 | 16 payments
|
| Fresenius USA Marketing | Velphoro | $139 | 7 payments
|
| Horizon Therapeutics plc | Krystexxa | $122 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $119 | 7 payments
|
| Janssen Pharmaceuticals | Xarelto | $59 | 3 payments
|
| Amgen | Parsabiv | $50 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $48 | 2 payments
|
| Akebia Therapeutics | Auryxia | $43 | 2 payments
|
2020: $528
| AstraZeneca Pharmaceuticals LP | Lokelma | $154 | 8 payments
|
| Amgen | Parsabiv | $103 | 4 payments
|
| OPKO Pharmaceuticals | Rayaldee | $103 | 6 payments
|
| Akebia Therapeutics | Auryxia | $86 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $61 | 4 payments
|
| Relypsa | Veltassa | $20 | 1 payment
|
2019: $607
| Akebia Therapeutics | Auryxia | $131 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $118 | 7 payments
|
| Fresenius USA Marketing | Velphoro | $97 | 5 payments
|
| Amgen | Aranesp | $80 | 3 payments
|
| OPKO Pharmaceuticals | Rayaldee | $70 | 4 payments
|
| Otsuka America Pharmaceutical | Jynarque | $54 | 3 payments
|
| Relypsa | Veltassa | $22 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $21 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 92.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1780607838
- Licence
- CA A93518California A93518: Current · expires 2027-11-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
- Mailing address
- 39233 Liberty St, Fremont, CA, 94538
- NPI first listed
- 2006-07-26
- NPI last updated
- 2011-04-20
This is when the NPI record was last certified, not a medical board exam.